Titan Pharmaceuticals
TTNP
#11035
Rank
โ‚น0.58 B
Marketcap
โ‚น437.72
Share price
-3.76%
Change (1 day)
24.39%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น416.83. In 2023 the company made an earnings per share (EPS) of -โ‚น703.58 an increase over its 2022 EPS that were of -โ‚น1,442.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น703.58-51.22%
2022-โ‚น1,442-15.61%
2021-โ‚น1,709-81.37%
2020-โ‚น9,172-77.52%
2019-โ‚น40,810-56.32%
2018-โ‚น93,432-59.51%
2017-โ‚น2,30,776-371.81%
2016โ‚น84,903-144.35%
2015-โ‚น1,91,421300%
2014-โ‚น47,855-121.54%
2013โ‚น2,22,185-151.38%
2012-โ‚น4,32,406-11.54%
2011-โ‚น4,88,807188.89%
2010-โ‚น1,69,202-10%
2009-โ‚น1,88,003
2007-โ‚น7,70,811-2.38%
2006-โ‚น7,89,611-39.13%
2005-โ‚น12,97,219-16.87%
2004-โ‚น15,60,422-22.43%
2003-โ‚น20,11,6294.9%
2002-โ‚น19,17,62761.9%
2001-โ‚น11,84,417-13.7%
2000-โ‚น13,72,42065.01%
1999-โ‚น8,31,733-35.87%
1998-โ‚น12,96,997-1824.71%
1997โ‚น75,201-102.4%
1996-โ‚น31,39,645

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น829.27-298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น632.37-251.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น439.62 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น71.21-117.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น21.84-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น413.03-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA